8HIDRON AI,EDWARDS JR,PATEL J,et a1.NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention,2006-2007[J].Infect Control Hosp Epidemiol,2008,29(11):996-1011.
2Arias CA,Murray BE.Antibiotic-resistant bugs in the 21st century-a clinical super-challenge[J].N Engl J Med,2009,360(5):439-443.
3Clinical and Laboratory Standads Institute.Performance Standards for Antimicrobial Susceptibility Testing[S].Fifteenth Informational Supplement,2010,M100-S20 Vol 30 No.1.
4Clinical and Laboratory Standads Institute Performance Standards for Antimicrobial Susceptibility Testing[S].Fifteenth Informational Supplement,2010,M100-S20-U Vol 30 No 15.
5Clinical Laboratory Standard Institute.Methods for Antimicrobial Dilution and Disk Susceptibility Testing of Infrequently Isolated or Fastidious Bacteria[S].Approved Guideline M45-A,Vol.26 No.19,2006.
6Wang P,Hu FP,Xiong ZZ,et al.Susceptibility of ESBL-Producing nterobacteriaceae with the New CLSI Breakpoints[J].J Clin Microbiol,2011,49(6):3127-3131.
7Yang Q,Wang H,Sun H,et al.Phenotypic and genotypic characterization of Enterobacteriaceae with decreased susceptibility to carbapenems:results from large hospital-based surveillance studies in China[J].Antimicrob Agents Chemother,2010,54(1):573-577.
8Wang H.Guo P,Sun HL,et al.Molecular epidemiology of clinical isolates of carbapenem-resistant Acinerobacter spp from Chinese hospitals[J].Antimicrob Agents Chemother.2007,51(11):4022-4028.
9陈东科,孙长贵.实用临床微生物学检验与图谱[M].北京:人民卫生出版社,2010:154.
10CLSI Performance standards for antimicrobial susceptibility testing[S]. Twenty second Informational supplement M100- S22 2012,32(3).
2Sader HS, Jones RN, Dowzicky MJ, et al. Antimicrobial activity of tigecycline tested against nosoeomial bacterial pathogens from pa- tients hospitalized in the intensive care unit [ J ]. Diagn Microbiol Infect Dis, 2005, 52(3) : 203 -208.
3Sood S, Malhotra M, Das BK, et al. Enteroeoeeal infections & an- timicrobial resistance [ J ]. Indian J Med Res, 2008, 128 ( 2 ) : 111 -121.
4Horodnieeanu T, Bougueleret L, E1 - Solh N, et al. High - level, plasmid- borne resistance to gentamicin in Streptococcus faecalis subsp, zymogenes [ J]. Antimierob Agents Chemother, 1979, 16 (5) : 686 - 689.
5Eliopoulos GM, Wennersten C, Zighelboim - Danm S, et al. High - level resistance to gentamicin in clinical isolates of Streptococcus ( Enteroeoeeus ) faecium [ J ]. Antimicrob Agents Chemother, 1988, 32(10) : 1528 -1532.
6Sifaoui F, Arthur M, Rice L, et al. Role of penicillin - binding protein 5 in expression of ampicillin resistance and peptidoglycan structure in Enterococcus faecium [ J ]. Antimicrob Agents Che- mother, 2001,45(9) : 2594 -2597.
7Rice LB, Carias LL, Hutton - Thomas R, et al. Penicillin - binding protein 5 and expression of ampicillin resistance in Enterococcus fae- cium [ J ]. Antimicrob Agents Chemother, 2001, 45 (5) : 1480 - 1486.
8Edmond MB, Wallace SE, Mcclish DK, et al. Nosocomial blood- stream infections in United States hospitals : a three - year analysis [J]. Clin Infect Dis, 1999, 29(2) : 239 -244.
9Lloyd SP, Younger J, Lloyd SE, et al. Economic analysis of vanco- mycin- resistant enterococci at a Canadian hospital: assessing at- tributable cost and length of stay [ J]. J Hosp Infect, 2013, 85 (1) : 54 -59.
